3byo
From Proteopedia
| Line 1: | Line 1: | ||
| - | + | {{Seed}} | |
| + | [[Image:3byo.jpg|left|200px]] | ||
| - | The | + | <!-- |
| + | The line below this paragraph, containing "STRUCTURE_3byo", creates the "Structure Box" on the page. | ||
| + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| + | or leave the SCENE parameter empty for the default display. | ||
| + | --> | ||
| + | {{STRUCTURE_3byo| PDB=3byo | SCENE= }} | ||
| - | + | ===X-Ray co-crystal structure of 2-amino-6-phenylpyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-one 25 bound to Lck=== | |
| - | Description: X-Ray co-crystal structure of 2-amino-6-phenylpyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-one 25 bound to Lck | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | <!-- |
| + | The line below this paragraph, {{ABSTRACT_PUBMED_18278858}}, adds the Publication Abstract to the page | ||
| + | (as it appears on PubMed at http://www.pubmed.gov), where 18278858 is the PubMed ID number. | ||
| + | --> | ||
| + | {{ABSTRACT_PUBMED_18278858}} | ||
| + | |||
| + | ==Disease== | ||
| + | Known disease associated with this structure: SCID due to LCK deficiency OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=153390 153390]] | ||
| + | |||
| + | ==About this Structure== | ||
| + | 3BYO is a 1 chain structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3BYO OCA]. | ||
| + | |||
| + | ==Reference== | ||
| + | Structure-based design of novel 2-amino-6-phenyl-pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activity., Martin MW, Newcomb J, Nunes JJ, Boucher C, Chai L, Epstein LF, Faust T, Flores S, Gallant P, Gore A, Gu Y, Hsieh F, Huang X, Kim JL, Middleton S, Morgenstern K, Oliveira-dos-Santos A, Patel VF, Powers D, Rose P, Tudor Y, Turci SM, Welcher AA, Zack D, Zhao H, Zhu L, Zhu X, Ghiron C, Ermann M, Johnston D, Saluste CG, J Med Chem. 2008 Mar 27;51(6):1637-48. Epub 2008 Feb 16. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/18278858 18278858] | ||
| + | [[Category: Homo sapiens]] | ||
| + | [[Category: Non-specific protein-tyrosine kinase]] | ||
| + | [[Category: Huang, X.]] | ||
| + | [[Category: Alternative splicing]] | ||
| + | [[Category: Atp-binding]] | ||
| + | [[Category: Chromosomal rearrangement]] | ||
| + | [[Category: Cytoplasm]] | ||
| + | [[Category: Disease mutation]] | ||
| + | [[Category: Host-virus interaction]] | ||
| + | [[Category: Kinase domain]] | ||
| + | [[Category: Lck]] | ||
| + | [[Category: Lipoprotein]] | ||
| + | [[Category: Membrane]] | ||
| + | [[Category: Myristate]] | ||
| + | [[Category: Nucleotide-binding]] | ||
| + | [[Category: Palmitate]] | ||
| + | [[Category: Phosphoprotein]] | ||
| + | [[Category: Proto-oncogene]] | ||
| + | [[Category: Sh2 domain]] | ||
| + | [[Category: Sh3 domain]] | ||
| + | [[Category: Transferase]] | ||
| + | [[Category: Tyrosine-protein kinase]] | ||
| + | |||
| + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Dec 31 10:15:16 2008'' | ||
Revision as of 08:15, 31 December 2008
Contents |
X-Ray co-crystal structure of 2-amino-6-phenylpyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-one 25 bound to Lck
Template:ABSTRACT PUBMED 18278858
Disease
Known disease associated with this structure: SCID due to LCK deficiency OMIM:[153390]
About this Structure
3BYO is a 1 chain structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Structure-based design of novel 2-amino-6-phenyl-pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activity., Martin MW, Newcomb J, Nunes JJ, Boucher C, Chai L, Epstein LF, Faust T, Flores S, Gallant P, Gore A, Gu Y, Hsieh F, Huang X, Kim JL, Middleton S, Morgenstern K, Oliveira-dos-Santos A, Patel VF, Powers D, Rose P, Tudor Y, Turci SM, Welcher AA, Zack D, Zhao H, Zhu L, Zhu X, Ghiron C, Ermann M, Johnston D, Saluste CG, J Med Chem. 2008 Mar 27;51(6):1637-48. Epub 2008 Feb 16. PMID:18278858
Page seeded by OCA on Wed Dec 31 10:15:16 2008
Categories: Homo sapiens | Non-specific protein-tyrosine kinase | Huang, X. | Alternative splicing | Atp-binding | Chromosomal rearrangement | Cytoplasm | Disease mutation | Host-virus interaction | Kinase domain | Lck | Lipoprotein | Membrane | Myristate | Nucleotide-binding | Palmitate | Phosphoprotein | Proto-oncogene | Sh2 domain | Sh3 domain | Transferase | Tyrosine-protein kinase
